干细胞移植后的巨细胞病毒感染 - Suppr

Suppr

超能文献

Cytomegalovirus infection following stem cell transplantation.

作者信息

Einsele H, Hebart H

机构信息

Medizinische Klinik und Poliklinik, University Hospital, Tübingen, Germany.

出版信息

Haematologica. 1999 Jun;84 Suppl EHA-4:46-9.

PMID:10907466

Abstract

摘要

相似文献

Cytomegalovirus infection following stem cell transplantation.

Haematologica. 1999 Jun;84 Suppl EHA-4:46-9.

Prevention and management of CMV-related problems after hematopoietic stem cell transplantation.

Bone Marrow Transplant. 2002 Apr;29(8):633-8. doi: 10.1038/sj.bmt.1703407.

Cidofovir for cytomegalovirus-preemptive therapy in stem cell transplant recipients.

Blood. 2001 Sep 1;98(5):1626; author reply 1628. doi: 10.1182/blood.v98.5.1626.

New therapies for cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome.

West J Med. 1997 Feb;166(2):138-9.

Cidofovir as primary pre-emptive therapy for post-transplant cytomegalovirus infections.

Bone Marrow Transplant. 2001 Nov;28(9):879-81. doi: 10.1038/sj.bmt.1703251.

Strategies for management of cytomegalovirus (CMV) infection after allogeneic bone marrow transplantation: the "doubling of baseline CMV pp65 antigenemia" and the "cidofovir as rescue treatment approaches.

Blood. 2001 Sep 1;98(5):1627-8; author reply 1628-9. doi: 10.1182/blood.v98.5.1627.

Cytomegalovirus in hematopoietic stem cell transplant recipients: Current status, known challenges, and future strategies.

Biol Blood Marrow Transplant. 2003 Sep;9(9):543-58. doi: 10.1016/s1083-8791(03)00287-8.

Donor CMV serostatus not predictive of relapse in D-/R- pediatric HCT.

Biol Blood Marrow Transplant. 2009 Jun;15(6):758-60. doi: 10.1016/j.bbmt.2009.03.025.

Management of human cytomegalovirus infection and disease after allogeneic bone marrow transplantation.

Haematologica. 1999 Jan;84(1):71-9.

[Diagnosis, treatment, and prophylaxis for cytomegalovirus disease following allogeneic stem cell transplantation].

Rinsho Ketsueki. 2003 Dec;44(12):1154-60.

引用本文的文献

Identification and characterization of human cytomegalovirus-encoded circular RNAs.

Front Cell Infect Microbiol. 2022 Nov 14;12:980974. doi: 10.3389/fcimb.2022.980974. eCollection 2022.

Human cytomegalovirus miR-US5-1 inhibits viral replication by targeting Geminin mRNA.

Virol Sin. 2017 Oct;32(5):431-439. doi: 10.1007/s12250-017-4064-x. Epub 2017 Oct 31.

The expression of interleukin-32 is activated by human cytomegalovirus infection and down regulated by hcmv-miR-UL112-1.

Virol J. 2013 Feb 12;10:51. doi: 10.1186/1743-422X-10-51.

Characterization of a novel Golgi apparatus-localized latency determinant encoded by human cytomegalovirus.

J Virol. 2009 Jun;83(11):5615-29. doi: 10.1128/JVI.01989-08. Epub 2009 Mar 18.

Adoptive transfer of cytomegalovirus-specific CTL to stem cell transplant patients after selection by HLA-peptide tetramers.

J Exp Med. 2005 Aug 1;202(3):379-86. doi: 10.1084/jem.20040613.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验